Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2020-06-03 Director's Dealing
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
109年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, general managers, and their family members. It lists the number of shares held, changes in holdings, and other related information. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or summary. Therefore, the appropriate classification is DIRS.
2020-06-03 Chinese
109年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related party holdings. It is a disclosure of insider shareholdings and pledges rather than a financial report, meeting announcement, or voting result. The document length is 3285 characters, which is relatively short and focused solely on insider shareholding data. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. There is no indication of financial results, meeting materials, or other report types. Therefore, the correct classification is DIRS with high confidence.
2020-06-03 Chinese
108年度股利金額(股東會決議)
Notice of Dividend Amount Classification · 100% confidence The document text primarily contains detailed information about dividend distribution, including cash dividends, stock dividends, dates of board resolutions and shareholder meetings, and related company policies. It is a formal announcement of dividend amounts and payment details for shareholders. There is no indication of a full annual or interim report, nor is it a brief mention or link to a report. The content matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2020-05-27 Chinese
本公司依公開發行公司資金貸與及背書保證處理準則 第二十五條第一項第三款及第四款規定公告
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a publicly listed company (杏輝) disclosing details about guarantees and endorsements provided for a subsidiary's bank financing. It includes specific financial figures related to the guarantee limits, outstanding balances, and related financial ratios. The document is short (1138 characters) and focuses on compliance with disclosure regulations regarding guarantees and endorsements, not on presenting a full financial report or audit. There is no indication of it being an annual or interim report, audit report, earnings release, or other detailed financial report. It is a regulatory disclosure about financial guarantees, fitting best under Regulatory Filings (RNS) as a general compliance announcement that does not fit other specific categories.
2020-05-27 Chinese
本公司擬於參與認購子公司杏國新藥(股)公司以私募方式 辦理現金增資發行之普通股新股
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a listed company (杏輝) regarding its intention to participate in a private placement capital increase of its subsidiary 杏國新藥. It details the transaction specifics such as the nature of the securities, transaction amount, relationship between parties, board approval dates, and accounting firm information. The document is short (2008 characters) and focuses on a capital financing event rather than a full financial report or earnings release. It does not contain financial statements or comprehensive financial analysis but rather an update on a financing transaction. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-05-27 Chinese
公告本公司董事會決議資本公積發放現金基準日
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement (678 characters) from a company (杏輝) regarding the board resolution on the cash distribution from capital surplus, including key dates such as ex-dividend date, record date, and payment date. It does not contain financial statements or detailed financial data but rather dividend-related information. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and related details to shareholders.
2020-05-27 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.